May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Bolus vs Standard Photodynamic Therapy in the Treatment of Circumscribed Choroidal Hemangioma: a Randomized, Masked Study.
Author Affiliations & Notes
  • E. Midena
    Department of Ophthalmology, University of Padova, Padova, Italy
  • E. Pilotto
    Department of Ophthalmology, University of Padova, Padova, Italy
  • P.P. Radin
    Department of Ophthalmology, University of Padova, Padova, Italy
  • V. de Belvis
    Department of Ophthalmology, University of Padova, Padova, Italy
  • Footnotes
    Commercial Relationships  E. Midena, None; E. Pilotto, None; P.P. Radin, None; V. de Belvis, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 3154. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. Midena, E. Pilotto, P.P. Radin, V. de Belvis; Bolus vs Standard Photodynamic Therapy in the Treatment of Circumscribed Choroidal Hemangioma: a Randomized, Masked Study. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):3154.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To analyze clinical and angiographic (indocyanine green angiography, ICGA) behaviour of circumscribed choroidal hemangioma (CCH) treated with different photodynamic therapy (PDT) regimens. Methods: Twelve consecutive symptomatic patients affected by CCH underwent PDT treatment of their lesion. PDT was randomly performed with two different treatment modalities: standard PDT treatment (verteporfin 6 mg/sqm; 30 ml IV in 10 min; treatment at 15 min; 50 J/sqcm; 83 sec) and bolus PDT treatment (verteporfin 6 mg/sqm; IV bolus in 2 min; treatment at 5 min; 100J/sqcm; 166 sec) . ICGA was performed pre–op, and: 10 minutes, 1 day, 1 and 4 weeks, and every 3 months post–op. Best corrected visual acuity (BCVA; ETRDS chart), fundus photography, microperimetry, OCT and ultrasonography were performed at each follow–up examination. Examiners were masked about PDT regimen.Results: Five patients were treated with standard PDT and seven with bolus regimen. Minimun follow–up was 8 months. One single treatment was performed in each patient. BCVA improved from one to four lines with both PDT treatment regimens, without significant difference between two groups. Microperimetry showed better long term retinal sensitivity over standard treated tumors ( p < .05) Subretinal fluid reabsorbed in all treated eyes. CCH flattened in both treatment groups, faster in bolus treated eyes. ICGA documented a massive involvement of choroidal circulation with PDT bolus, and progressive disappearance of pre–op characteristics in both treatment groups. Reactive pigment epithelium hyperplasia was signicantly more evident in the bolus PDT treated eyes (p< .005). Conclusions: The management of CCH should critically consider long term side effects of any proposed modality. PDT seems to be a promising and safe modality for the treatment of symptomatic CCH, but long term effects of PDT on normal (and neoplastic) choroidal circulation, retinal pigment epithelium and retinal sensitivity need to be adequately considered.

Keywords: tumors • photodynamic therapy • imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×